港股異動 | 中升控股(0881.HK)五連漲 股價再創新高
格隆匯5月26日丨中升控股(0881.HK)漲逾2%,暫錄5連漲,報64.8港元,高見65.05港元,連續第二日創歷史新高,最新總市值1500億港元。美銀證券發佈最新報吿,將中升控股目標價由71港元上調至80港元,重申“買入”評級。報吿中稱,公司日前宣佈提前贖回2023年到期的零息可轉換債券,目前其僅有2025年到期的45.6億元未到期可換股債券尚未償還,轉換價為45.61港元。此前該行假設,公司所有可換股債券將全部轉換為股份數量,因為所有可換股債券均在價內。美銀證券表示,看好其豪華車市場以及售後市場的增長潛力。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.